Two Patients With Macular Degeneration Get Artificial Retinas Two Patients With Macular Degeneration Get Artificial Retinas
Two patients in Lyon have been among the first people to receive an artificial retina implant as part of a multicenter clinical trial testing the safety and efficacy of the PRIMA implant system.Medscape Medical News (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - January 21, 2022 Category: Opthalmology Tags: Ophthalmology News Source Type: news

Sports mouthguards: Contamination, roughness, and chlorhexidine for disinfection - A randomized clinical trial
 Braz Dent J. Nov-Dec 2021;32(6):66-73.doi: 10.1590/0103-6440202104533.AbstractThe aim of the present in vivo study was to evaluate the bacterial contamination of sports mouthguards, surface roughness, and the efficacy of chlorhexidine gluconate spray in the disinfection of these devices. A randomized, blinded cross-over clinical trial was performed with twenty 9 to 13 years old children who practiced martial arts and participated in all phases of the study. They were instructed to wear mouthguards 3 alternated days a week for 1 hour and, after use, to spray sterile tap water or chlorhexidine 0.12%. The mouthguar...
Source: Dental Technology Blog - January 21, 2022 Category: Dentistry Source Type: news

Lessons learned from two clinical trials on nutritional supplements to reduce aggressive behaviour - de Bles NJ, Gast DAA, van der Slot AJC, Didden R, van Hemert AM, Rius-Ottenheim N, Giltay EJ.
BACKGROUND: Setting up and conducting a randomised controlled trial (RCT) has many challenges-particularly trials that include vulnerable individuals with behavioural problems or who reside in facilities that focus on care as opposed to research. These pop... (Source: SafetyLit)
Source: SafetyLit - January 21, 2022 Category: International Medicine & Public Health Tags: Program and Other Evaluations, Effectiveness Studies Source Type: news

Decreases in suicidality following psychedelic therapy: a meta-analysis of individual patient data across clinical trials - Zeifman RJ, Yu D, Singhal N, Wang G, Nayak SM, Weissman CR.
OBJECTIVE: Suicide is a global health concern, and innovative interventions that target suicidality are needed. While psychedelic therapy shows promise for a range of mental health concerns, including suicidality, not all psychedelic therapy trials have pu... (Source: SafetyLit)
Source: SafetyLit - January 21, 2022 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

Elon Musk's Neuralink could soon implant its brain chip in HUMANS
Neuralink posted a job listing for a clinical trial director who will 'work with Neuralink's first Clinical Trial participants.' This suggests the company will soon implant its brain chips in humans. (Source: the Mail online | Health)
Source: the Mail online | Health - January 20, 2022 Category: Consumer Health News Source Type: news

Elon Musk's Neuralink could soon implant its brain chip in HUMANS
Neuralink posted a job listing for a clinical trial director who will 'work with Neuralink's first Clinical Trial participants.' This suggests the company will soon implant its brain chips in humans. #elonmusk #clinicaltrial #clinicaltrialdirector (Source: Reuters: Health)
Source: Reuters: Health - January 20, 2022 Category: Consumer Health News Source Type: news

Elon Musk ’s brain chip firm Neuralink lines up clinical trials in humans
Implants that Musk says could allow paralysed people to walk already tested on a macaque and a pig #neuralink #pigimplants #elonmusk (Source: Reuters: Health)
Source: Reuters: Health - January 20, 2022 Category: Consumer Health News Source Type: news

Florida Study Coordinator Sentenced in Scheme to Falsify Clinical Drug Trial Data
FDA OCI, Duniel Tejeda, Clewiston FL, project manager, study manager, Miami, Tellus Clinical Research, $2.1 million, restitution, falsify data, medical records, clinical trials, evaluate, opioid dependency, irritable bowel syndrome (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - January 20, 2022 Category: Medical Law Authors: DOJ Source Type: news

Is Musk ’s brain implant company moving closer to human trials?
Neuralink, Elon Musk’s brain implant firm, is hiring a clinical trial director. #brainimplantfirm #elonmusk #clinicaltrialdirector #brainimplantcompany #humantrials (Source: Reuters: Health)
Source: Reuters: Health - January 20, 2022 Category: Consumer Health News Source Type: news

Elon Musk ’s brain chip firm Neuralink lines up clinical trials in humans
Implants that Musk says could allow paralysed people to walk already tested on a macaque and a pigThe billionaire entrepreneur Elon Musk ’s brain chip startup is preparing to launch clinical trials in humans.Musk, who co-founded Neuralink in 2016, haspromised that the technology “will enable someone with paralysis to use a smartphone with their mind faster than someone using thumbs”.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - January 20, 2022 Category: Science Authors: Rupert Neate Wealth correspondent Tags: Elon Musk Artificial intelligence (AI) Neuroscience Technology Business Source Type: news

Methods and efficacy of social support interventions in preventing suicide: a systematic review and meta-analysis
Question Suicide is a global public and mental health problem. The effectiveness of social support interventions has not been widely demonstrated in the prevention of suicide. We aimed to describe the methods of social support interventions in preventing suicide and examine the efficacy of them. Study selection and analysis We searched literature databases and conducted clinical trials. The inclusion criteria for the summary of intervention methods were as follows: studies aimed at preventing suicide through method(s) that directly provide social support; use of one or more method(s) to directly provide social support. Th...
Source: Current Awareness Service for Health (CASH) - January 20, 2022 Category: Consumer Health News Source Type: news

U.S. Researchers Test Pig-to-Human Transplant in Donated Body
Researchers on Thursday reported the latest in a surprising string of experiments in the quest to save human lives with organs from genetically modified pigs. This time around, surgeons in Alabama transplanted a pig’s kidneys into a brain-dead man—a step-by-step rehearsal for an operation they hope to try in living patients possibly later this year. “The organ shortage is in fact an unmitigated crisis and we’ve never had a real solution to it,” said Dr. Jayme Locke of the University of Alabama at Birmingham, who led the newest study and aims to begin a clinical trial of pig kidney transplants....
Source: TIME: Health - January 20, 2022 Category: Consumer Health News Authors: LAURAN NEERGAARD / AP Tags: Uncategorized healthscienceclimate Source Type: news

Newly Published Study on Successful Pig-to-Human Kidney Transplant Newly Published Study on Successful Pig-to-Human Kidney Transplant
First published account of successful pig-to-human transplant in a brain-dead recipient opens the door to clinical trials in animal-to-human kidney donation.Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 20, 2022 Category: Surgery Tags: Nephrology News Source Type: news

Doctors Successfully Transplanted A Gene-Edited Pig Kidney – And They Have Plans To Scale Up
The successful transplantation by scientists at University of Alabama-Birmingham into a brain-dead human body paves the way to clinical trials — and hope for thousands of patients suffering kidney disease. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 20, 2022 Category: Pharmaceuticals Authors: Alex Knapp, Forbes Staff Tags: Science /science Innovation /innovation Healthcare /healthcare Editors' Pick editors-pick technology alexknappblog Source Type: news

Kidneys From a Genetically Altered Pig Are Implanted in a Brain-Dead Patient
Surgeons at the University of Alabama at Birmingham said they hoped to start clinical trials with kidney patients later this year. (Source: NYT Health)
Source: NYT Health - January 20, 2022 Category: Consumer Health News Authors: Roni Caryn Rabin Tags: your-feed-science Kidneys Transplants Pigs Surgery and Surgeons Genetic Engineering American Journal of Transplantation University of Alabama at Birmingham Source Type: news

Pfizer Covid Vaccine For Kids Under 5 Could Be Authorized In The Next Month, Fauci Says
Pfizer is working on a three-dose regimen of its vaccine for young children after a two-dose course produced disappointing results in clinical trials. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 19, 2022 Category: Pharmaceuticals Authors: Zachary Snowdon Smith, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Source Type: news

Ethnic Disparities Seen in Enrollment for a Clinical Trial ​
29 percent of patients deemed appropriate for intervention were Hispanic compared with 52 percent of those deemed not appropriate (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - January 19, 2022 Category: Respiratory Medicine Tags: Family Medicine, Pediatrics, Pulmonology, Journal, Source Type: news

Decentralized clinical trial platform Thread scoops up voice tech inVibe
The acquisition  is expected to help Thread customers capture real-world data.  (Source: mobihealthnews)
Source: mobihealthnews - January 19, 2022 Category: Information Technology Source Type: news

Ethnic Disparities Seen in Enrollment for a Clinical Trial ​
WEDNESDSAY, Jan. 19, 2022 -- In the Bronchiolitis Follow-up Intervention Trial (BeneFIT) setting, physicians more often determined that Hispanic patients were not appropriate for as-needed follow-up and excluded them from the trial, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 19, 2022 Category: Pharmaceuticals Source Type: news

‘Nocebo effect’: two-thirds of Covid jab reactions not caused by vaccine, study suggests
US researchers show negative version of placebo effect behind many symptoms such as headaches and fatigueMore than two-thirds of the common side-effects people experience after a Covid jab can be attributed to a negative version of the placebo effect rather than the vaccine itself, researchers claim.Scientists in the US examined data from 12 clinical trials of Covid vaccines and found that the “nocebo effect” accounted for about 76% of all common adverse reactions after the first dose and nearly 52% after the second dose.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - January 19, 2022 Category: Science Authors: Ian Sample Science editor Tags: Medical research Vaccines and immunisation Coronavirus Health Infectious diseases Science US news World news Source Type: news

23andMe is getting $50M from GSK to extend their research partnership
Drug giant GlaxoSmithKline plc will fork over $50 million to 23andMe Holding Co. to extend their partnership by another year until July 2023. The two companies have been collaborating since 2018 on finding targets for potential drugs. One such treatment is already in clinical trials, and the companies have identified more than 40 other potential treatment targets. As part of the partnership, GSK is tapping into the genetic database Sunn yvale-based 23andMe has assembled from its at-home consumer… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - January 19, 2022 Category: Health Management Authors: Ron Leuty Source Type: news

COVID-19 vaccine trial participants report side effects even with placebos
Nearly one-third of COVID-19 vaccine clinical trial participants given a placebo as part of studies reported experiencing side effects after receiving the sham product, a JAMA Network Open analysis found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 18, 2022 Category: Consumer Health News Source Type: news

FDA Workshop: Clinical Trial Design for Non-Muscle Invasive Bladder Cancer (NMIBC) - 11/18/2021
The U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) and Center for Drug Evaluation and Research (CDER) welcome you to this FDA Virtual Public Workshop: Clinical Trial Design for Non-Muscle Invasive Bladder Cancer (NMIBC). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 18, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Dermaliq Therapeutics Signs USD 15 Million Series A Round to Advance Three Transformative Drug Therapies into Clinical Trials
Dermaliq Therapeutics, Inc. is an independent private pharmaceutical company emerged from Novaliq Spin-off to unlock value in the space of medical dermatology by using Novaliq's transformative technology outside eye care 3E Bioventures Capital and Be... Biopharmaceuticals, Dermatology, Venture Capital Dermaliq Therapeutics, alopecia, psoriasis, soft tissue infection (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 18, 2022 Category: Pharmaceuticals Source Type: news

Stempeutics gets DCGI nod for Phase 3 clinical trial on its product for treating COVID patients
Stempeucel exhibits potent immuno-modulatory and anti-inflammatory properties which could help in reducing the inflammation caused due to the cytokine storm elicited by the body's immune cells in response to SARS-CoV-2 (COVID-19) related infection in the lungs, Stempeutics said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 18, 2022 Category: Pharmaceuticals Source Type: news

How The mRNA Vaccines Were Made: Halting Progress and Happy Accidents
The stunning Covid vaccines manufactured by Pfizer-BioNTech and Moderna drew upon long-buried discoveries made in the hopes of ending past epidemics. (Source: NYT Health)
Source: NYT Health - January 15, 2022 Category: Consumer Health News Authors: Gina Kolata and Benjamin Mueller Tags: Clinical Trials Coronavirus (2019-nCoV) Vaccination and Immunization National Institutes of Health MERS (Middle East Respiratory Syndrome) Acquired Immune Deficiency Syndrome Graham, Barney S (1953- ) Kariko, Katalin (1955- ) Fauci, Anthon Source Type: news

After layoffs, Peninsula biotech company looks to sublease offices, labs
The company cut three-quarters of its workforce late last year after the clinical trial failures of two drugs. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - January 14, 2022 Category: Health Management Authors: Ron Leuty Source Type: news

What's the accuracy of crowdsourcing the screening of search results? Help Cochrane find out!
Cochrane Crowd is a citizen science platform  where a global community of volunteers help to classify the research needed to support informed decision-making about healthcare. Cochrane Crowd volunteers review descriptions of research studies to identify and classify clinical trials. A new task has just gone live on Cochrane Crowd. It is a citation screening task that we are doing in partnership withThe Healthcare Improvement Studies Institute (THIS Institute).It forms a part of a methodological study that aims to assess the accuracy of crowdsourcing the screening of search results. Unlike some of t...
Source: Cochrane News and Events - January 14, 2022 Category: Information Technology Authors: Lydia Parsonson Source Type: news

Belong.Life rolls out online community for patients with chronic myeloid leukemia
Patients can use the service to access support groups, navigation tools  and a clinical trial-matching program.  (Source: mobihealthnews)
Source: mobihealthnews - January 13, 2022 Category: Information Technology Source Type: news

Dexcom's Kevin Sayer talks new G7 clinical trial data
The company also unveiled its 2021 revenue.   (Source: mobihealthnews)
Source: mobihealthnews - January 13, 2022 Category: Information Technology Source Type: news

Immune-Based Drug, Pembrolizumab, Fights Advanced Endometrial Cancer: Study
THURSDAY, Jan. 13, 2022 -- A drug used to treat several types of cancer is also an effective treatment for aggressive forms of endometrial cancer, the second most common cancer in women worldwide, a new clinical trial shows. The endometrium is the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 13, 2022 Category: General Medicine Source Type: news

Shorter Course of Anticoagulant Therapy Adequate for Provoked VTE in Children Shorter Course of Anticoagulant Therapy Adequate for Provoked VTE in Children
For children with acute provoked venous thromboembolism, 6 weeks of anticoagulant therapy is as effective as a three-month course of anticoagulant therapy, results of a new clinical trial suggest.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - January 13, 2022 Category: Intensive Care Tags: Emergency Medicine News Source Type: news

Response to Radiotherapy for Prostate Cancer Better in Black Men
Outcomes better for Black men compared with White men in clinical trials of definitive radiotherapy for localized prostate cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 12, 2022 Category: Cancer & Oncology Tags: Oncology, Radiology, Urology, Journal, Source Type: news

What is informed consent?
This video explains what informed consent means in clinical trials participation. (Source: National Institute of Mental Health)
Source: National Institute of Mental Health - January 12, 2022 Category: Psychiatry Authors: National Institute of Mental Health Source Type: news

Florida Co-Owner of Clinical Trial Company Pleads Guilty to Obstructing FDA Inspection
FDA OCI, Olga Torres, Miami FL, plea, guilty, obstruction, regulatory, inspection, alleged, scheme, fraud, falsify, clinical drug trial, data, research, site, Unlimited Medical ch, safety, efficacy, asthma medication, children, Yvelice Villaman Bencosme, Lisett Raventos, Mayte Lledo, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - January 12, 2022 Category: Medical Law Authors: DOJ Source Type: news

Medicare Proposes Restricting Coverage Of Aduhelm To Alzheimer ’s Patients Who Enroll In Clinical Trials
On January 11, Medicare issued a draft memorandum that it will only pay for Aduhelm under the so-called coverage with evidence development (CED) pathway. On one hand, proponents say Medicare can learn whether the drug works in the context of a CED study. On the other, critics say CED impedes access. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 12, 2022 Category: Pharmaceuticals Authors: Joshua Cohen, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news

What a Peninsula biotech company learned when its future was on the line
Allogene is pioneering off-the-shelf cell therapy using gene editing, so when the FDA placed a clinical hold on its clinical trials in the fall, it went to work to find answers for itself and the emerging field. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - January 12, 2022 Category: Health Management Authors: Ron Leuty Source Type: news

Response to Radiotherapy for Prostate Cancer Better in Black Men
WEDNESDAY, Jan. 12, 2022 -- Among men with localized prostate cancer enrolled in clinical trials for definitive radiotherapy, Black men have better outcomes than White men, according to a review published online Dec. 29 in JAMA Network Open. Ting... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 12, 2022 Category: Pharmaceuticals Source Type: news

Mesothelioma Specialty Centers Factor in 2021 Best Hospital Rankings
University of Texas MD Anderson Cancer Center in Houston is No. 1 for the seventh consecutive year on the prestigious U.S. News & World Report Best Hospitals for Cancer list. The annual cancer rankings were included in the media company’s recently published Best Hospitals 2022 guidebook. Cancer is one of the 15 specialties for which hospitals in the U.S. were ranked. Other hospitals in the top five are: Memorial Sloan Kettering Cancer Center in New York City; Mayo Clinic in Rochester, Minnesota; Dana-Farber/Brigham and Women’s Hospital in Boston and the Cleveland Clinic Cancer Center. Mesothelioma ...
Source: Asbestos and Mesothelioma News - January 12, 2022 Category: Environmental Health Authors: James Fannon Source Type: news

South African Studies Suggest Omicron Has Higher'Asymptomatic Carriage'South African Studies Suggest Omicron Has Higher'Asymptomatic Carriage '
Preliminary findings from two South African clinical trials suggest the Omicron coronavirus variant has a much higher rate of'asymptomatic carriage'than earlier variants.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 12, 2022 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Novartis and Molecular Partners report positive topline data from Phase 2 study for ensovibep (MP0420), a DARPin antiviral therapeutic for COVID-19
Novartis and Molecular Partners announced that Part A of the EMPATHY clinical trial(1) that compared single intravenous doses of ensovibep, a DARPin antiviral therapeutic candidate vs. placebo to treat COVID-19, met the primary endpoint of viral load reduction over eight days. The two secondary endpoints also showed clinically meaningful benefit over placebo - (1) composite endpoint of hospitalization and/or Emergency Room (ER) visits or death, and (2) time to sustained clinical recovery. (Source: World Pharma News)
Source: World Pharma News - January 12, 2022 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news

Medicare Proposes to Only Cover Alzheimer's Drug Aduhelm for Use in Clinical Trials
Title: Medicare Proposes to Only Cover Alzheimer's Drug Aduhelm for Use in Clinical TrialsCategory: Health NewsCreated: 1/11/2022 12:00:00 AMLast Editorial Review: 1/12/2022 12:00:00 AM (Source: MedicineNet Alzheimer)
Source: MedicineNet Alzheimer - January 12, 2022 Category: Geriatrics Source Type: news

Medicare Intends to Limit Payment for Controversial Alzheimer's Drug Medicare Intends to Limit Payment for Controversial Alzheimer's Drug
CMS seeks to limit pay for aducanumab and expected similar follow-on drugs to cases where people are enrolled in clinical trials.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - January 12, 2022 Category: Neurology Tags: Psychiatry News Alert Source Type: news

Medicare Proposes to Sharply Limit Coverage of the Alzheimer ’s Drug Aduhelm
If the preliminary decision is finalized this spring, it would restrict coverage to patients in randomized clinical trials. (Source: NYT Health)
Source: NYT Health - January 12, 2022 Category: Consumer Health News Authors: Pam Belluck Tags: Drugs (Pharmaceuticals) Aduhelm (Drug) Elderly Alzheimer ' s Disease Medicare Centers for Medicare and Medicaid Services Biogen Inc your-feed-healthcare Source Type: news

Clinical performance of direct composite resin versus indirect restorations on endodontically treated posterior teeth: A systematic review and meta-analysis
ConclusionsFor the short term (2.5 to 3 years), low-quality evidence suggests no difference in tooth survival or restoration quality. To assess the influence of the type of restoration on the survival and restorative success of endodontically treated posterior teeth, clinical trials that control for the amount of coronal tooth tissue and other baseline characteristics are needed.Clinical ImplicationsFor the short term (2.5 to 3 years), low-quality evidence suggests no difference in tooth survival or restoration quality for direct composite resin or indirect restorations on endodontically treated posterior teeth. (Source: D...
Source: Dental Technology Blog - January 12, 2022 Category: Dentistry Source Type: news

Medicare proposes covering expensive Alzheimer's drug for those in clinical trials
(Source: NPR Health and Science)
Source: NPR Health and Science - January 12, 2022 Category: Consumer Health News Authors: Jonathan Franklin Source Type: news

Medicare Proposes to Only Cover Alzheimer's Drug Aduhelm for Use in Clinical Trials
TUESDAY, Jan. 11, 2022 -- It's a move that could severely limit the number of people taking the controversial new Alzheimer's drug Aduhelm: Medicare on Tuesday proposed to only cover the cost of the pricey medication for people enrolled in approved... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 11, 2022 Category: General Medicine Source Type: news

Medicare proposes to cover controversial Alzheimer's drug with restrictions
Medicare has proposed covering the controversial and costly Alzheimer's drug Aduhelm only for those enrolled in qualifying clinical trials, the Centers for Medicare and Medicaid Services announced... #aduhelm #alzheimer (Source: Reuters: Health)
Source: Reuters: Health - January 11, 2022 Category: Consumer Health News Source Type: news

Medicare plans to cover Biogen drug only for patients in clinical trials
Medicare will only cover the cost of Aduhelm, the Alzheimer's drug made by Biogen Inc., for certain patients enrolled in clinical trials if the feds stick to a preliminary decision issued by the Centers for Medicare and Medicaid Services (CMS). The federal agency posted a proposed decision to its website on Tuesday afternoon. Biogen (Nasdaq: BIIB) shares began to slide in after-hours trading, dropping by about 6% in the first hour after the closing bell. The final CMS decision will not come until… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - January 11, 2022 Category: Health Management Authors: Rowan Walrath Source Type: news

Clario, XingImaging expand PET partnership
Clinical trial management services firm Clario, formerly ERT and Bioclinca...Read more on AuntMinnie.comRelated Reading: Bioclinica acquires clinical trial AI firm BioClinica rolls out new WebSend release BioClinica teams with Mirada for molecular imaging (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 11, 2022 Category: Radiology Source Type: news